Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02774681
Title Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

Her2-receptor positive breast cancer

Therapies

Trastuzumab

Palbociclib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.